Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivity

Authors:

Abstract
No abstract available
Funding Information
  • National Research Foundation of Korea
  • Direktion für Entwicklung und Zusammenarbeit
  • Eisai (AN4169/EPL-BS497, EPL-BS1246, EPL-BS967)
  • Department for International Development, UK Government
  • Drugs for Neglected Diseases initiative
  • Bundesministerium für Forschung, Technologie und Raumfahrt
  • Ministry of Science, ICT and Future Planning (2007-00559)
  • Korea Institute of Science and Technology Information
  • Médecins Sans Frontières

This publication has 61 references indexed in Scilit: